High-Risk Prescribing Increases Rates of New Persistent Opioid Use in Total Hip Arthroplasty Patients
Delaney LD, Gunaseelan V, Rieck H, Dupree JM 4th, Hallstrom BR, Waljee JF. High-Risk Prescribing Increases Rates of New Persistent Opioid Use in Total Hip Arthroplasty Patients [published online ahead of print, 2020 Apr 14]. J Arthroplasty. 2020;S0883-5403(20)30349-1. doi:10.1016/j.arth.2020.04.019
- Patients of surgeons with the highest rates of high-risk prescribing were more likely to develop persistent use compared with patients of surgeons with the lowest rates (adjusted rates: 9.7% vs 4.6%)
- Patients of surgeons with initial prescription sizes in the “high” (third) quartile and of surgeons in the “highest” (fourth) quartile of 30-day prescription dosage were more likely to develop persistent opioid use compared with patients of surgeons with low initial and 30-day prescription sizes, respectively.
- While the development of persistent opioid use after surgery is multifactorial, surgeon prescribing patterns play an important role.
- Reducing prescribing and encouraging opioid alternatives could minimize postoperative persistent opioid use.